1. Home
  2. CING vs BFRG Comparison

CING vs BFRG Comparison

Compare CING & BFRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • BFRG
  • Stock Information
  • Founded
  • CING 2012
  • BFRG 2017
  • Country
  • CING United States
  • BFRG United States
  • Employees
  • CING N/A
  • BFRG N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • BFRG Retail: Computer Software & Peripheral Equipment
  • Sector
  • CING Health Care
  • BFRG Technology
  • Exchange
  • CING Nasdaq
  • BFRG Nasdaq
  • Market Cap
  • CING 13.1M
  • BFRG 14.8M
  • IPO Year
  • CING 2021
  • BFRG 2023
  • Fundamental
  • Price
  • CING $4.16
  • BFRG $1.64
  • Analyst Decision
  • CING Strong Buy
  • BFRG
  • Analyst Count
  • CING 3
  • BFRG 0
  • Target Price
  • CING $16.00
  • BFRG N/A
  • AVG Volume (30 Days)
  • CING 78.2K
  • BFRG 159.6K
  • Earning Date
  • CING 05-07-2025
  • BFRG 05-09-2025
  • Dividend Yield
  • CING N/A
  • BFRG N/A
  • EPS Growth
  • CING N/A
  • BFRG N/A
  • EPS
  • CING N/A
  • BFRG N/A
  • Revenue
  • CING N/A
  • BFRG N/A
  • Revenue This Year
  • CING $82.10
  • BFRG N/A
  • Revenue Next Year
  • CING N/A
  • BFRG N/A
  • P/E Ratio
  • CING N/A
  • BFRG N/A
  • Revenue Growth
  • CING N/A
  • BFRG N/A
  • 52 Week Low
  • CING $1.80
  • BFRG $1.43
  • 52 Week High
  • CING $20.83
  • BFRG $4.84
  • Technical
  • Relative Strength Index (RSI)
  • CING 52.65
  • BFRG 38.97
  • Support Level
  • CING $3.95
  • BFRG $1.54
  • Resistance Level
  • CING $4.44
  • BFRG $2.16
  • Average True Range (ATR)
  • CING 0.27
  • BFRG 0.16
  • MACD
  • CING 0.07
  • BFRG 0.01
  • Stochastic Oscillator
  • CING 66.89
  • BFRG 16.13

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About BFRG Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Share on Social Networks: